See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI102.37▼ 0.87%
← QED page
XStocksXray
Market X-Ray report · 23 October 2026

Quadrise Plc (QED)

London Exchange · UK · prices in GBX · close of 23 Oct 2026

Key indicators

Last closeGBX 0.942
52-week range0.850 – 3.650
Return, 1 month / 3 months−20.8% / −8.8%
Return, 1 year / 3 years−70.7% / +25.6%
TrendBelow its 200-day average
RSI (14)44
Volatility (1 year)103.8%
Worst drawdown (1 year)-73.0%
Average daily value traded3.60M GBX
Dividend yield–

Market X-Ray price-based

17/ 100 · High confidence · ahead of 7% of stocks on this exchange
Trend3
Momentum11
Stability (higher is calmer)6
Liquidity65
Income–

Five-year price chart navy: price · brown: 200-day average

0.242.184.126.068.002021-102023-012024-042025-072026-10

About the company

Quadrise Plc develops emulsion fuel technology and supplies alternative liquid fuels to heavy industry. Its products include emulsified fuels made from refinery residues and biofuel blends, marketed under names such as MSAR and bioMSAR. These fuels are designed for customers in shipping, power generation and industrial heating, offering a substitute for conventional heavy fuel oil in boilers, engines and furnaces. The company is based in the United Kingdom and works with partners to commercialise its fuel formulations.

Quadrise Plc trades under the code QED on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Quadrise Plc (QED) trades on the London Exchange in UK. It last closed at GBX 0.942 on 23 October 2026.

Its price-based Market X-Ray is 17 out of 100 (a weak price profile), ranking 3,530 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 70.7% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Quadrise Plc (QED)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend3 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-47.2%
From 52-week high-71.5%
Momentum11 · WeakLagging most stocks on this exchange.
3-month return-8.8%
6-month return-66.9%
12-month return, skipping the last month-62.9%
Stability (higher is calmer)6 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)103.8%
Worst drawdown, 1 year (smaller is calmer)-73.0%
Liquidity65 · FairModerate trading activity.
Average daily value traded3.60M GBX
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−6.7%
1 month−20.8%
3 months−8.8%
6 months−66.9%
1 year−70.7%
3 years+25.6%
5 years−74.3%

Signals

50-day / 200-day average1.027 / 1.785
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.120

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026